News Chart Monte Rosa Therapeutics, Inc.

Stocks

GLUE

US61225M1027

Biotechnology & Medical Research

Market Closed - Nasdaq 06:00:00 25/09/26 am AEST			5-day change	1st Jan Change
11.72 ^USD	-1.43%		-6.98%	-25.26%

09/09	Top Midday Stories: GE Aerospace to Acquire Consolidated Precision Products; Qualcomm Issues Share Warrant to Amazon	MT
08/09	Monte Rosa Therapeutics Initiates Phase 2 Clinical Study for Vav1-Directed Molecular Glue Degrader MRT-6160	CI

f7115b42f0698042ff.ceSpvBwCTWnalSQfgiWz-W4EuVx29MRLmKub5GR9B6k.CNPq-0Q3GQeXym8y-EHAzUN-5jsujrN70N3dlh4zKv5BjMHta2gEAJjgEA~308914a47fc4d081fa542b3cdafbc3eb